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Abstract
Lanthanide DOTA-tetraglycinate (LnDOTA-(gly)4
2) complexes contain four magnetically equivalent amide protons that
exchange with protons of bulk water. The rate of this base catalyzed exchange process has been measured using chemical
exchange saturation transfer (CEST) NMR techniques as a function of solution pH for various paramagnetic LnDOTA-(gly)4
2
complexes to evaluate the effects of lanthanide ion size on this process. Complexes with Tb(III), Dy(III), Tm(III) and Yb(III)
were chosen because these ions induce large hyperfine shifts in all ligand protons, including the exchanging amide protons.
The magnitude of the amide proton CEST exchange signal differed for the four paramagnetic complexes in order,
Yb.Tm.Tb.Dy. Although the Dy(III) complex showed the largest hyperfine shift as expected, the combination of
favorable chemical shift and amide proton CEST linewidth in the Tm(III) complex was deemed most favorable for future in
vivo applications where tissue magnetization effects can interfere. TmDOTA-(gly)4
2 at various concentrations was
encapsulated in the core interior of liposomes to yield lipoCEST particles for molecular imaging. The resulting nanoparticles
showed less than 1% leakage of the agent from the interior over a range of temperatures and pH. The pH versus amide
proton CEST curves differed for the free versus encapsulated agents over the acidic pH regions, consistent with a lower
proton permeability across the liposomal bilayer for the encapsulated agent. Nevertheless, the resulting lipoCEST
nanoparticles amplify the CEST sensitivity by a factor of ,10
4 compared to the free, un-encapsulated agent. Such pH
sensitive nano-probes could prove useful for pH mapping of liposomes targeted to tumors.
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Introduction
agnetic resonance imaging (MRI) is a powerful diagnostic tool
for clinical imaging. The intensity of a proton MR signal is
determined by numerous factors including tissue proton density,
relaxation rates (T1 and T2), pulse sequence, blood flow and
molecular diffusion effects. Paramagnetic MRI contrast agents are
often used to enhance inherent contrast differences between
tissues. Current clinical agents are largely based on paramagnetic
gadolinium complexes which operate by shortening the relaxation
times of the bulk water protons in their immediate vicinity [1]. A
new class of agents called chemical exchange saturation transfer
(CEST) agents has recently emerged that alter image contrast by
reducing the total water signal intensity via chemical exchange of
pre-saturated proton spins into the pool of water. The first CEST
agents introduced by Balaban and co-workers [2,3,4] were
diamagnetic molecules containing NH and/or OH protons that
exchange with bulk water protons. Later, paramagnetic CEST
agents (PARACEST) were shown to have some advantages over
diamagnetic agents because the exchange sites in these agents tend
to be shifted well away from the tissue water frequency so they are
more readily saturated without inadvertent saturation of tissue
water itself [5,6]. A large chemical shift difference is also
advantageous in that faster exchanging systems can be used for
CEST imaging. Although Bloch theory predicts that a PARA-
CEST agent with the optimal exchange rate will have comparable
sensitivity to conventional Gd(III)-based T1 contrast agent, the
number of such agents identified to date with exchange rates
optimal for CEST are limited.
One way of magnifying CEST sensitivity is through the use of
nano-systems which can sequester high concentration of ex-
changeable CEST sites within a small volume. Liposomes, a class
of nano-systems, are spherical vesicles made up of one or more
phospholipid bilayers. The phospholipid bilayer serves to separate
the aqueous internal core of the liposomes from the surrounding
medium. Liposomes provide a good platform for CEST since the
encapsulated internal water protons can exchange with the
external water protons by diffusion through the semi-permeable
bilayer. Aime and co-workers have taken advantage of this signal
enhancement effect by encapsulating a water shift reagent, Tm-
DOTMA (not a PARACEST agent), in liposomes to shift the
resonance frequency of the encapsulated water molecules away
from the frequency of bulk water [7]. The entrapped, shifted water
proton resonance then serves as a strong saturation antenna to
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27370initiate CEST. The resulting lipoCEST particles extend the
sensitivity of CEST into the sub-nanomolar range.
It has been demonstrated that LnDOTA-(gly)4
2 contains two
chemical types of exchange sites, the Ln(III)-bound water protons
and the amide protons [8]. Terreno et al., examined the CEST
properties of these complexes previously and paid particular
attention to the pH sensitivity of the amide protons in this series
[9]. They proposed that one could use a combination of two
different LnDOTA-(gly)4
2 complexes, one showing favorable
CEST from a slowly exchanging bound water molecule (insensi-
tive to pH) and another showing favorable CEST from the highly
shifted –NH protons (sensitive to pH), to establish a ratiometric
method for imaging the pH of solution. Although promising, the
relatively low sensitivity of CEST from any small molecule agent
remains the major limitation for in vivo studies. In this work, we
explored the potential of encapsulating LnDOTA-(gly)4
2 inside
liposomes as a method to enhance CEST sensitivity. LnDOTA-
(gly)4
2 complexes are highly water soluble, are relatively non-toxic
in animals [10], and can be loaded into liposomes without the
need for further chemical modification.
Results
The lanthanide complexes of DOTA-(gly)4 (Fig. 1) form a single
species in solution whose conformation corresponds to a mono-
capped square antiprism (SAP). The
1H-NMR of the LnDOTA-
(gly)4
2 matched perfectly with a spectrum published previously
[8]. The CEST spectra of the four lanthanide complex recorded
are compared in Fig. 2. The spectra were obtained by stepping the
frequency of the presaturation pulse from +100 ppm to
2100 ppm while monitoring the effects of saturation on the water
amplitude. The magnitude of the water proton intensity
normalized to 1 (Ms/Mo) is then plotted against the saturation
offset at constant power. Pre-saturation of the bulk water at 0 ppm
reduced Ms/Mo to ,0% in all samples. However, a second CEST
exchange peak was observed in each spectrum that could be
assigned to –NH proton exchange. These appeared at +77 ppm,
+62 ppm, 216 ppm and 251 ppm for Dy-, Tb-, Yb- and
TmDOTA-(gly)4
2, respectively.
The CEST dependence on pH was also evaluated for each of
the four LnDOTA-(gly)4
2 complexes. The CEST data for
TmDOTA-(gly)4
2 are shown in Fig. 3. To allow for easy
comparison of the CEST response of all four LnDOTA-(gly)4
2
complexes, these CEST data are displayed in graphical form in
Fig. 4. The CEST effect is markedly pH-dependent showing an
increase in CEST with pH values above 6.2 and reaching a
maximum around pH 8–8.5. Since the amide proton exchange is
accelerated by base, a lack of CEST below pH ,6.2 indicates that
proton exchange is too slow to meet the CEST requirement. As
the pH is increased between 6 and 8, the CEST signal gradually
increases in intensity for all agents as –NH proton exchange
becomes faster. Around pH 8 to 8.5, the rate of proton exchange
reaches an optimal value for CEST and above this pH region,
-NH proton exchange becomes too fast, and the CEST signal
intensity once again decreases as the –NH proton resonance
begins to coalesce into the bulk water signal. The pH profile of
YbDOTA-(gly)4
2 reported by Aime and co-workers showed a
linear pH dependence in the pH range of 5.5–8.1, in reasonable
agreement with data presented here for YbDOTA-(gly)4
2 [11].
Among the four lanthanide complexes examined here, the –NH
resonance of TmDOTA-(gly)4
2 displayed a 3-fold larger chemical
shift than YbDOTA-(gly)4
2 while maintaining a relatively strong
CEST signal compared to those of DyDOTA-(gly)4
2 and
TbDOTA-(gly)4
2. For these reasons, we chose the Tm(III)
complex for encapsulation into liposomes for further CEST
amplification.
It is important to show that the liposomes are stable toward
leakage of the encapsulated agent at different temperatures and
pH values to ensure that the CEST signal reflects agent inside the
liposome core and does not arise from agent that may have leaked
out. Release of TmDOTA-(gly)4
2 at different temperatures was
first evaluated by dialyzing a suspension of liposomes containing
the agent against 300 milliosmolar (mOsm) NaCl at three different
temperatures, 275 K, 298 K and 310 K. It is important to
maintain the same osmolality on both sides of the liposomal
bilayer to prevent shrinkage or bursting of the liposomes due to
differences in osmotic pressure. Aliquots of dialysate were removed
at different time points and analyzed for total Tm(III) using ICP-
MS. As shown in Fig. 5, less than 1% of the total TmDOTA-
(gly)4
2 loaded into liposomes was released over the 2 day period at
the three temperatures examined. These profiles show that the
liposome formulation is stable at the temperatures tested.
To evaluate the pH stability of the liposomal formulation, the
liposomes were suspended at different pH values for 24 hr, then
dialyzed against 300 mOsm NaCl at 298 K. Again, any released
Tm(III) was monitored using ICP-MS. Figure 6 shows that less
than 1% of the total Tm(III) complex leaked from the liposome
interior when exposed in acid (pH 5.5) or base (pH 8.0) within
24 hr. Again, this provides evidence for a stable liposome
formulation at different pH values.
Prior to pH dependent CEST studies, the amount of entrapped
TmDOTA-(gly)4
2 per nanoparticle was optimized by systemati-
cally varying the concentration of TmDOTA-(gly)4
2 in the stock
solution used during preparation of liposomes from 50–150 mM.
It was assumed that the concentration of TmDOTA-(gly)4
2 in the
stock solution used in the hydration process was equivalent to the
concentration agent entrapped inside the liposome core volume
after liposomal preparation and purification. The resulting
liposomes had a hydrodynamic diameter of 98–104 nm with low
polydispersity index confirming their narrow size distribution
(Table 1). Elemental analysis confirmed that liposomes prepared
from stock solutions containing 50 mM TmDOTA-(gly)4
2 had the
lowest thulium to phospholipid (Tm:P) ratio while those prepared
from solutions containing 150 mM TmDOTA-(gly)4
2 had the
highest Tm:P ratio, as expected.
Amide proton CEST from liposome-encapsulated TmDOTA-
(gly)4
2 was assessed at mild basic (pH 7.7) and mild acidic
(pH 6.6) conditions by adjusting the pH using 300 mOsm HEPES
or MES buffer. Figure 7 shows a plot of the intensity of amide
proton CEST intensity as a function of agent concentration at two
different pH values. In all cases, the total bulk solution
Figure 1. Molecular structure of LnDOTA-tetraglycinate
(LnDOTA-(gly)4
2 where Ln refers to the indicated lanthani-
de(III) ions).
doi:10.1371/journal.pone.0027370.g001
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PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27370Figure 2. CEST spectra of the four LnDOTA-(gly)4 complexes. Each complex (20 mM, pH 7.5, 310 K) shows a different amide proton chemical
shift with respect to the bulk water (dH2O=0 ppm). The spectra were collected at 9.4 T using a frequency-selective, presaturation pulse over the
frequency range 6100 ppm (B1=21.2 mT, 2 s for Tm-, Dy-, Tb-DOTA-(gly)4
2 and 4 s for YbDOTA-(gly)4
2).
doi:10.1371/journal.pone.0027370.g002
Figure 3. CEST spectra of TmDOTA-(gly)4
2 collected at different pH values. Each spectrum was recorded at 9.4 T on 20 mM samples at
pH 7.5 and 310 K. (B1=21.2 mT, presaturation time=2 s).
doi:10.1371/journal.pone.0027370.g003
Figure 4. Amide proton CEST intensity versus pH for the four different LnDOTA-(gly)4
2 complexes. Each amide proton CEST intensity
was recorded on 20 mM samples at 9.4 T, 310 K and the indicated pH after application of a frequency-selection presaturation pulse set to the
frequency of the exchanging –NH proton characteristic of each complex (B1=21.2 mT, presaturation time=4 s (YbDOTA-(gly)4
2) or 2 s (TmDOTA-
(gly)4
2, TbDOTA-(gly)4
2, DyDOTA-(gly)4
2).
doi:10.1371/journal.pone.0027370.g004
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2 in each sample was adjusted to
3 mM by varying the liposome concentration so that liposomes
with 150 mM encapsulated agent were 3-fold more dilute (on a
liposome basis) compared to samples containing liposomes with
50 mM encapsulated agent. This allowed a direct comparison of
each liposome preparation while maintaining an identical bulk
concentration of TmDOTA-(gly)4
2 in each sample (3 mM).
As expected for a system undergoing base-catalyzed amide
proton exchange, a higher CEST signal was observed at more basic
pH values, reaching a plateau of about 10%CEST for encapsulated
agent concentrations above ,75 mM. A similar trend was observed
at pH 6.6but,inthis case,the maximum CEST was,7%. Atagent
concentrations below 75 mM, the CEST signal decreased and was
not detectable for agent concentrations below ,40 mM.
Figure 5. Plot of amount of TmDOTA-(gly)4
2 released from liposomes (%) as a function of time. TmDOTA-(gly)4
2 was measured
analytically in the extraliposomal medium during incubation of liposomes at 275 K, 298 K and 310 K over a span of 48 hr.
doi:10.1371/journal.pone.0027370.g005
Figure 6. In vitro stability of a liposomal suspension at different pH values (n=2). TmDOTA-(gly)4
2 was measured analytically in the
extraliposomal medium after incubation of liposomes at 298 K for 24 hr at several different pH values.
doi:10.1371/journal.pone.0027370.g006
Table 1. Hydrodynamic diameter, polydispersity index and
thulium-phosphorus ratio of the liposomes at different
concentrations of the encapsulated TmDOTA-(gly)4
2.
[Stock solution of Tm
DOTA-(gly)4
2] (mM) Diameter (nm)
Polydispersity
index Tm:P
50 101 0.037 0.09
60 104 0.053 0.10
75 98 0.083 0.11
150 103 0.118 0.33
doi:10.1371/journal.pone.0027370.t001
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function of pH for unencapsulated TmDOTA-(gly)4
2 (no lipid) at
three different agent concentrations. The general shape of these
pH curves were similar at all three agent concentrations, consistent
with base-catalyzed –NH proton exchange. A maximum CEST
signal was reached at similar pH values (,7.6) and, as anticipated,
the CEST signal was larger for the sample containing the most
agent. However, for an increase in agent concentration from 3 to
20 mM (6.67-fold), the maximum CEST signal at pH 7.6 (the
maximum in these curves) only increased from 12 to 20%, a 1.67-
fold increase. This indicates that CEST does not vary linearly with
agent concentration at pH 7.6. A further increase in agent
concentration from 20 to 75 mM resulted only in an additional
2% increase in CEST.
The pH dependence of amide proton CEST for two different
liposome preparations (75 mM and 150 mM encapsulated agents)
each at a total TmDOTA-(gly)4
2 concentration of 3 mM are
compared with a similar curve for 3 mM unencapsulated
TmDOTA-(gly)4
2 (no lipid, same data as shown in Fig. 8) in
Figure 9. The CEST versus pH profiles for two encapsulated
samples is clearly quite different from that collected for the
unencapsulated agent free in solution. Both the free and
encapsulated samples reached a maximum CEST intensity near
pH ,7.6 but the CEST profile was considerably flatter and
identical forthetwo encapsulatedagentsinthelowerpHregions.At
basic pH values (pH.7), a smaller CEST intensity was observed for
the encapsulated TmDOTA-(gly)4
2 samples, likely reflecting the
extra barrier for the exchanging protons to equilibrate into the bulk
solvent. At lower pH values, the CEST signal from the
unencapsulated agent decreases with typical sigmoid behavior to a
value approaching zero by pH 6.0. The two encapsulated samples,
however, showed a much more modest decrease in CEST intensity
Figure 7. Amide proton CEST intensity from liposomal-encapsulated TmDOTA-(gly)4
2. Each amide proton CEST intensity was measured
at the frequency of the exchanging –NH protons (-51 ppm) in an aqueous suspension of liposomes filled with TmDOTA-(gly)4
2 in the inner core (the
indicated concentrations were for the stock solutions of TmDOTA-(gly)4
2 used in preparing the liposomes) at 9.4 T and 310 K. (B1=7.0 mT;
presaturation time=6 s).
doi:10.1371/journal.pone.0027370.g007
Figure 8. Amide proton CEST intensity versus pH for three different concentrations of TmDOTA-(gly)4
2. No lipid was present in this
experiment. The amide proton CEST intensity was measured at 9.4 T and 310 K using a B1=7.0 mT and a presaturation time of 6 s.
doi:10.1371/journal.pone.0027370.g008
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displayed a larger CEST intensity at all pH values below pH,7.3as
compared to the unencapsulated sample at identical pH values.
Discussion
The pH sensitivity of the exchangeable amide protons of
LnDOTA-tetraamide complexes makes such complexes attractive
for pH sensing using CEST principles. In this study, pH
dependent CEST curves were presented for four different
LnDOTA-(gly)4
2 complexes (where Ln=Yb, Tm, Tb or Dy).
The differences in chemical shifts of the amide protons in these
complexes were due to the intrinsic magnetic anisotropy of the
lanthanide ions, arising from pseudocontact or hyperfine interac-
tions [12]. In addition, the inherently short spin-spin relaxation
time (T2) of Tm(III) is evidenced by the broadening of the bulk
water peak in the CEST spectrum of TmDOTA-(gly)4
2 (Fig. 2).
It is well known that amide proton exchange is accelerated by a
base so a change in solution pH results in a change in CEST
response. Thus, pH dependent CEST curves were collected for the
four different LnDOTA-(gly)4
2 complexes (Fig. 4). Among the
four complexes examined, YbDOTA-(gly)4
2 showed the largest
CEST intensity at all pH values, followed by TmDOTA-(gly)4
2.
The Tb(III) and Dy(III) complexes showed similar and smaller
CEST intensities at all pH values. The variation in CEST signal
amplitude for the four complexes has been attributed to
differences in the intrinsic paramagnetic properties of the
lanthanide metal, expressed as the effective magnetic moment
(meff) [9]. A large magnetic moment effectively reduces both T1
and T2 of water protons and, since the amide proton CEST
intensity is in competition with T1, a longer T1 will allow transfer
of more saturated spins before those spins return to equilibrium.
Solutions of the Yb(III) complex, being the least paramagnetic (by
virtue of its low meff) among the four lanthanide ions examined
here, had the longest T1 and this in turn translated to the largest
CEST signal (Table 2).
It is important to point out that the decrease in CEST above
pH 8–8.5 does not reflect complete dissociation of the amide
proton over the pH range studied here but rather changes in
amide proton exchange rates over this range of pH values. The
pKa’s of the amide protons in complexes such as LnDOTA-(gly)4
2
are much higher and typically too high to be easily discerned by
pH potentiometry [13,14]. The present data illustrates that the
optimal –NH proton exchange rate for CEST occurs well below
the pH at which complete dissociation of an amide proton occurs.
The relatively small chemical shift of the -NH protons in the
Yb(III) complex relative to bulk water may pose additional
problems in vivo because of the added complexities of the
background tissue MT signal [15]. One way to minimize
interference from the MT signal is to use a LnDOTA-(gly)4
2
complex that has a more highly shifted –NH proton exchange
resonance. On the basis of chemical shift and CEST magnitudes of
the four complexes studied here, the Tm(III) complex was chosen
for encapsulation into liposomes for further CEST studies.
A major limitation of applying CEST agents such as these is
their inherently low sensitivity, typically requiring millimolar agent
concentrations for detection. One way to improve CEST
sensitivity is to amplify the signal by using a nanoparticle assembly
such as a liposome. Here, the local concentration of the agent can
be amplified substantially by sequestering a large number of
lanthanide complexes within the inner core of the nanoparticle.
Liposomes can also serve as delivery vehicles for CEST agents to
Figure 9. Comparison of amide proton CEST intensities versus pH for free and liposome-encapsulated TmDOTA-(gly)4
2. The amide
proton CEST intensity for free TmDOTA-(gly)4
2 sample (3 mM, no lipid, same data as that shown in Fig. 8) and liposomal-encapsulated TmDOTA-
(gly)4
2 (intraliposomal concentrations of 75 mM and 150 mM) were measured as a function of pH at 9.4 T and 310 K using a B1=7.0 mT and a
presaturation time of 6 s. The number of liposomes in the later two samples was adjusted so that the total concentration of TmDOTA-(gly)4
2 in each
sample was 3 mM when averaged over the entire volume.
doi:10.1371/journal.pone.0027370.g009
Table 2. The effective magnetic moment (meff) [9] of the four
lanthanide ion complexes and the measured T1 (sec) 6 s.d. of
bulk water in 20 mM samples of LnDOTA-(gly)4
2.
Ln meff
Bulk water
T1 (sec) of Ln-1
CEST (%)
1-(Mon/Moff)
Yb 4.5 1.8660.01 49
Tm 7.6 0.5360.01 25
Dy 10.6 0.2460.01 15
Tb 9.7 0.2560.01 17
All data were collected at 9.4 T, 310 K on samples adjusted to pH 7.5.
doi:10.1371/journal.pone.0027370.t002
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been reported that the inherent leaky vasculature of tumors
coupled with the increased capillary permeability of stealth
liposomes results in localization of liposomes in tumors without a
specific targeting component [16]. This could, in principle,
increase the effective concentration of CEST agent at targeted
site of interest several fold.
These results stimulated further studies on encapsulation of one
or more of these pH reporters in the internal cavity of liposomes.
Since the liposomal membrane is semi-permeable to water, the pH
of the extra-liposomal environment should be correctly reported by
a pH reporter molecule trapped in the interior compartment. The
fraction of the internal water in close proximity to the trapped
Ln(III) complex is small in comparison to the amount of extra-
liposomal water so the interior water molecules and/or protons
must exchange with extra-liposomal water to amplify the CEST
signal. A liposomal formulation was chosen that consisted of a
saturated phospholipid, 1,2-dipalmitoyl-sn-glycero-3-phosphocho-
line (DPPC), cholesterol and 1,2-distearoyl-sn-glycero-3-phos-
phoethanolamine-N-[methoxy (polyethylene glycol)-2000] (DSPE-
mPEG-2000) in a molar ratio of 55:40:5 [17,18,19]. Inclusion of
saturated phospholipids such as DPPC makes the lipid packing
more compact and insertion of cholesterol provides additional
stability to the bilayer membrane [20,21,22]. Inclusion of lipid
derivatives of polyethylene glycol (PEG) in the bilayer was done to
prolong the blood circulation time of liposomes by reducing their
uptake by mononuclear phagocytes (MPS) [23]. This formulation
has been used to encapsulate gadolinium and other multimodal
contrast agents where a sustained contrast enhancement due to
increased circulation half lives was exhibited by the liposomes in the
vasculature of a rat model as compared to the free agents [17,18].
The size of the liposome was maintained at less than 200 nm to
provide longer circulation times and to facilitate proton transport
acrossthe bilayer dueto highersurface area to volume ratio[17,24].
Different amounts of TmDOTA-(gly)4
2 were encapsulated in
liposomes to determine the optimal agent concentration. The data
in Fig. 7 illustrates that maximum CEST is reached with only
75 mM encapsulated TmDOTA-(gly)4
2.
The CEST signal intensity may be described by equation 1
[25,26].
%CEST~ 1{
Mon
Moff
  
100~
kexnagent½Agent 
111:2(T1)
{1zkexnagent½Agent 
 !
100
ð1Þ
Here, Mon and Moff are the signal intensities of the bulk water protons
at the on- and off-resonance positions, 111.2 is the molar
concentration of water protons in solution, and the term nH2O[Agent]
[Agent] refers to the number (n) of exchangeable protons per agent
molecule – four in this case. This equation indicates that faster
exchange rates (within the limits of the CEST limit kex,Dv), longer
water proton spin-lattice relaxation times (T1), higher agent
concentrations [Agent], and a larger number of exchangeable protons
on the agent (nagent) all result in a higher CEST signal. This equation
also illustrates that CEST is proportional to agent concentration only
for those conditions when 111.2(T1)
21&kexnagent[agent]. At higher
agent concentrations, the second term in the denominator dominates
and the CEST signal gradually becomes independent of agent
concentration, becoming more dependent on other factors such a
reduction in water proton T1 brought about by the higher
concentrations of weakly paramagnetic agent.
Encapsulation of TmDOTA-(gly)4
2 into phospholipid-based
liposomes was found to buffer the amide proton CEST intensity
versus pH response in the more acidic regions as presented in
Figure 9. This interesting observation likely reflects a change in
membrane permeability of the lipid bilayer at the different pH
values. Although zwitterionic phosphocholine (PC) is regarded as
an ‘‘inert molecule’’, studies have shown that acidification of the
PC bilayer modifies lipid mobility and consequently the mem-
brane permeability [27]. It has been reported that an increased
lipid order and an immobilized acyl chains were observed upon
lowering the pH from 7 to 4. At the liquid-crystalline phase or at
temperatures near the transition temperature (Tc) of the
phospholipid (Tc of DPPC is 42uC), partial protonation of the
PC headgroups may reduce the lipid mobility either by changing
the conformational and/or packing changes in the PC headgroup.
This change in the lipid bilayer reportedly inhibits release of K
+
(mediated by an ionophore, valinomycin, which catalyzes release
of K
+), consistent with a decrease in conductance of proton and
hydroxide in the PC bilayers [27]. In these preparations, the pH of
the original liposomal suspension before addition of buffer was
around 7.5. As the pH of the extra-liposomal solution was reduced
by addition of acid, the CEST signal remained relatively
unchanged (,3% decrease between pH 7 and 6) but was larger
in magnitude at all pH values below 7 than the CEST signal
generated by the free, unencapsulated agent. This suggests
impedance in the transport of H
+ across the bilayer as the pH is
lowered causing the internal pH to remain closer to the original
pH of 7.5 while the pH of the exterior, as monitored by a pH
electrode, is lower. One possible way to overcome the proton
transport limitation is to render the liposomes less rigid to allow
easier transfer of protons across the bilayer. This can be achieved
by lowering the cholesterol content in the phospholipid bilayer or
by using a less saturated phospholipid. However, one must insure
that liposome stability not be compromised by changing the
bilayer formulation.
One can compare the sensitivity of a liposome-encapsulated
versus unencapsulated CEST agent by comparing the concentra-
tions required to produce a 5% decrease in bulk water signal
intensity [9,28]. For this system, 1 mM TmDOTA-(gly)4
2 (no
lipid) was required to produce a 5% decrease in water signal while
the concentration of liposomes required to produce the same
amide proton CEST intensity was ,100 nM liposome (deter-
mined for a preparation that contained 75 mM encapsulated
agent). This 10
4 gain in sensitivity makes responsive lipoCEST
agents such as those illustrated here an attractive platform for
molecular imaging. Nano-carriers such as these could also be
valuable for measuring pH without knowing the exact agent
concentration by ratiometric imaging [29]. One could envision
entrappment of two different CEST agents (with different exchange
frequencies and pH sensitivities) in the interior of a liposome and
using the ratio of two CEST spectra to obtain a direct readout of
pH. This would also eliminate any concerns about potential
differences in tissue biodistribution for the two agents.
Materials and Methods
The preparation of LnDOTA-(gly)4
2 was previously reported
by Aime et al. using an ethyl ester protecting group (8). Here, we
report an alternative synthesis using the tert-butyl ester protecting
group with comparable yields.
General procedures
All commercially available reagents were used as received,
unless stated otherwise. Solution pH was measured using a double
pH-Sensitive LipoCEST Agents for MRI
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without temperature correction.
1H NMR,
13C NMR and CEST
spectra were recorded on a Bruker Avance spectrometer (
1Ha t
400.13 MHz,
13C at 100.61 MHz). Infrared spectra were
recorded using a Perkin Elmer 1600 Fourier Transform IR
spectrometer. Melting points were recorded on a Fisher/Johns
melting point apparatus and are uncorrected.
Synthesis
tert-Butyl-2-(2-bromoacetamido)acetate (2). Glycine-tert-
butyl ester hydrochloride (25 g, 148 mmol) and potassium
carbonate (103 g, 746 mmol) were dissolved in water (300 mL)
and dichloromethane (300 mL) was then added. The biphasic
reaction mixture was cooled to 0uC and a solution of
bromoacetylbromide (14 mL, 161 mmol) in dichloromethane
(140 mL) was added dropwise. The reaction was stirred at 0uC
for 30 min, then allowed to warm to room temperature and stirred
at this temperature an additional 18 hr. The organic layer was
collected and washed with 5% aqueous citric acid (46100 mL) and
water (36150 mL) before drying over sodium sulfate. The solvent
dichloromethane was removed under reduced pressure and the
remaining residue was recrystallized in ethyl acetate. The crystals
were filtered to afford tert-butyl-2-(2-bromoacetamido)acetate (2)
as a colorless solid (31.0 g, 83%). Mp=87–88uC.
1H-NMR
(400 MHz, CDCl3): d 6.97 (1H, s br, NH), 3.97 (2H, d,
2JH-
H=5 Hz, NHCH2), 3.91 (2H, s, CH2Br), 1.49 (9H, s, C(CH3)3).
13C-NMR (400 MHz, CDCl3): d 168.3 (CO2), 165.7 (NHC=O),
82.7 (C(CH3)3), 42.5 (NHCH2CO), 28.6 (BrCH2), 28.00 (C(CH3)3).
IR nmax/cm
21 (KBr disk): 3261 (NH), 3087, 2978, 1738 (C=O),
1651 (C=O), 1574, 1410, 1378, 1228, 1176, 1039, 664. Anal. calcd
for C8H14BrNO3: C, 38.1; H, 5.6;N 5.6.Found: C, 36.7, H,5.1; N,
5.9.
1,4,7,10- tetraazacyclododecane-1,4,7,10-tetra-(tert-butyl-
acetamidoacetate) (3). Cyclen (850 mg, 5.00 mmol) and
potassium carbonate (3.63 g, 26 mmol) were suspended in
acetonitrile (200 mL) and stirred for 20 minutes at 60uC.
Bromoacetamide 2 (5.16 g, 20 mmol) was added and the reaction
mixture was stirred at 60uC for 3 days and then allowed to cool to
room temperature. The mixture was filtered and the solvents were
removed in vacuo to give an oily residue. The residue was taken up in
dichloromethane (250 mL) and washed with brine (36100 mL).
The organic extracts were collected, dried over Na2SO4,a n d
solvent dichloromethane was removed in vacuo to afford 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetra-(tert-butyl-acetamidoacetate)
(3) as a pale yellow hygroscopic solid (4.0 g, 83%). Mp: 185–186uC.
1H-NMR (400 MHz, CDCl3): d 7.48 (4H, s br, NH), 3.83 (8H, d,
2JH-H=6 Hz, HNCH2CO), 3.09 (8H, s, NCH2CO), 2.68 (16H, s,
ringNCH2),1.38(36H,s,C(CH3)3).
13C-NMR(400 MHz,CDCl3):
d 171.3 (CO2), 169.1 (CONH), 81.9 (C(CH3)3), 59.2 (NCH2CO),
53.4 (ring NCH2), 41.6 (NHCH2CO), 28.0 (C(CH3)3). IR nmax/
cm
21 (KBr disk): 3202 (NH), 2976, 2836, 1747 (C=O), 1670
(C=O), 1551, 1457, 1369, 1225, 1159, 1034. m/z (ESMS EI+): 879
(100%, [M+Na
+], Anal. Calcd for C40H72N8O12.KBr: C, 49.2; H,
7.4; N 11.5. Found: C, 50.5, H, 7.3; N, 11.6.
1,4,7,10- tetraazacyclododecane-1,4,7,10-tetraacetamidoacetate
(1). Excess trifluoroacetic acid (TFA) was added to tert-butyl ester 2
(3.75 g, 0.00438 mol) and stirred for 18 hours. TFA was then removed in
vacuo and the oily residue was dissolved in diethyl ether (40 mL) and stirred
for 30 min. The white precipitate that formed was filtered and washed with
cold diethyl ether (26 20 mL). The solid precipitate was then taken up in
water (30 mL) and lyophilized. DOTA-(gly)4(1) was obtained as a colorless
solid (4.1 g, 83%). Mp: 89–92uC.
1H-NMR (400 MHz, D2O): d3.61 (8H,
s, NHCH2CO), 3.06 (8H, s, NCH2CO), 2.55 (16H, s, ring NCH2).
13C-
NMR (400 MHz, D2O): d176.8 (CO2), 173.4 (CONH), 57.1 (NCH2CO),
50.8 (ring NCH2), 43.1 (NHCH2CO). IR nmax/cm
21 (KBr disk): 3346
(OH), 2971, 2723, 1734 (C=O), 1684 (C=O), 1559, 1456, 1379, 1189,
1034. m/z (ESMS EI+): 633 (67%, [M+H
+]), 655 (100%, [M+Na
+]). Anal.
Calcd for C24H40N8O12.3CF3COOH.H2O . K B r :C ,3 3 . 0 ;H ,4 . 4 ;N9 . 9 .
Found: C, 33.1, H, 4.1; N, 9.6.
Preparation of lanthanide complexes
LnDOTA-(gly)4
2 complexes were prepared by mixing an
equimolar amount (0.643 mmol) of the ligand and the corre-
sponding lanthanide chloride (Ln=Tb, Dy, Tm, Yb) in 5 mL of
water. The pH of the solution was maintained near pH 6 using
3 N NaOH at room temperature. The progress of the lanthanide
complexation was followed by reverse-phase HPLC using a
Phenomenex Luna amino (NH2) column, 5 mm (15063.0 mm).
The absorbance was monitored at 210 nm and the solvent system
elution started with 100% acetonitrile:water (15:85) followed by a
linear gradient to 15% acetonitrile:water (15:85) and 85% 20 mM
phosphate buffer (pH 7.0) over 15 min and was further main-
tained for 5 min, at a flow rate of 1 mLmin
21 (chelate
tR=4.68 min; ligand tR=15.84 min). The complex was concen-
trated by lyophilization then redissolved in a minimum amount of
methanol:water (30:10). Tetrahydrofuran was added to the
solution dropwise until precipitate began to form and turbidity
persisted. The mixture was stirred for 17 hr in an ice bath followed
by centrifugation. Lyophilization of the precipitate yielded a white
solid.
TmDOTA-(gly)4
2.
1H NMR (400 MHz, in H2O at pH 7.50,
25uC, ref. dH2O=0 ppm): d 253.3 (4H, s, ring NCH2, axial), 37.7
(4H, s, ring NCH2, equatorial), 27.6 (4H, s, 4H, ring NCH2,
equatorial), 29.6 (4H, s, NHCH2CO), 219.7 (4H, s,
NHCH2CO), 255.1 (4H, s br, NH), 281.7 (4H, s, NCH2CO),
293.3 (4H, s, ring NCH2, axial), 2169.2 (4H, s, NCH2CO). m/z
(ESMS EI+): 843 (100%, [M
2+2Na
+]
+).
YbDOTA-(gly)4
2.
1H-NMR (400 MHz, in H2Oa tp H 7 ,
25uC, ref. dH2O=0 ppm): d 92.4 (4H, s, ring NCH2, axial), 13.2
(4H, s, ring NCH2, equatorial), 10.2 (4H, s, ring NCH2,
equatorial), 24.4 (4H, s, NHCH2CO), 28.3 (4H, s,
NHCH2CO), 217.4 (4H, s br, NH), 230.5 (4H, s, NCH2CO),
235.9 (4H, s, ring NCH2, axial), 262.2 (4H, s, NCH2CO). m/z
(ESMS EI+): 848 (100%, [M
2+2Na
+]
+), 879 (27%, [M
2+2K
+]
+).
TbDOTA-(gly)4
2.
1H-NMR (400 MHz, in H2Oa tp H 7 ,
25uC, ref. dH2O=0 ppm): d 203.7 (4H, s, NCH2CO), 103.3 (4H,
s, ring NCH2, axial), 66.7 (4H, s br, NH), 54.1 (4H, s, NCH2CO),
29.0 (4H, s, NHCH2CO), 22.8 (4H, s, NHCH2CO), 286.1 (4H, s,
ring NCH2, equatorial), 288.5 (4H, s, ring NCH2, equatorial),
2320.9 (4H, s, ring NCH2, axial). m/z (ESMS EI+): 833 (100%,
[M
2+2Na
+]
+).
DyDOTA-(gly)4
2.
1H-NMR (400 MHz, in H2Oa tp H 7 ,
25uC, ref. dH2O=0 ppm): d 240.7(4H, s, NCH2CO), 124.3 (4H,
s, ring NCH2, axial), 82.4 (4H, s br, NH), 76.6 (4H, s, NCH2CO),
32.6 (4H, s, NHCH2CO), 24.0 (4H, s, NHCH2CO), 289.2 (8H, s,
ring NCH2, equatorial), 2375.7 (4H, s, ring NCH2, axial). m/z
(ESMS EI+): 837 (100%, [M
2+2Na
+]
+).
CEST experiments
NMR samples for CEST studies were prepared by adding
0.10 M LnDOTA-(gly)4
2 (100 mL) in 10 mM 2-(N-morpholi-
no)ethanesulfonate (MES) buffer for pH 5.5–6.5, 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonate (HEPES) buffer for pH 6.5–
8.5 and Tris buffer for pH 8.5 to 9.5 (400 mL). LipoCEST samples
were prepared by adding 1.41 mM liposome encapsulating mono-
sodium LnDOTA-(gly)4 (300 mL) in 10 mM 2-(N-morpholino)etha-
nesulfonate (MES) buffer for pH 5.5–6.5, 4-(2-hydroxyethyl)-1-
piperazineethanesulfonate (HEPES) buffer for pH 6.5–8.5 and Tris
pH-Sensitive LipoCEST Agents for MRI
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the total solution osmolarity to 300 mOsm (200 mL). The
experiment was carried out by irradiating the sample with a
continuous wave presaturation pulse at a power level of 21.2, 16.5,
11.8 or 7.0 mT for 2–4 s (2 s for TmDOTA-(gly)4
2, TbDOTA-
(gly)4
2, DyDOTA-(gly)4
2 and 4 s pulse duration for YbDOTA-
(gly)4
2) over a range of frequencies followed by a single observe
pulse to measure the residual water signal. The CEST signal was
defined by difference in intensities of the bulk water signal after a
presaturation pulse set to the frequency of the exchanging –NH
proton (Mon) minus at the same offset frequency but on the opposite
side with respect to the bulk water signal (Moff). This method
removes any effects due to indirect saturation of the bulk water
signal.
Preparation of liposomes
A lipid mixture of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC) (Avanti Polar Lipids, Inc., Alabama, USA), Cholesterol
(Avanti PolarLipids, Inc., Alabama, USA) and 1,2-distearoyl-sn-
glycero-3-phosphoethanolamine-N-[methoxy (poly(ethylene gly-
col))-2000] (DSPE-mPEG2000) (Avanti PolarLipids, Inc., Ala-
bama, USA) in the molar ratio of 55:40:5 was dissolved in absolute
ethanol (volume of absolute ethanol was 10% of the total batch
volume) at 50uC. A solution of the lanthanide complex (40 mM)
was subsequently added to the ethanol solution to achieve a lipid
concentration of 150 mM. The solution was stirred for 90 minutes
at 50uC and then sequentially extruded using a Lipex Thermoline
extruder (Northern Lipids, Vancouver, British Columbia, Canada)
with five passes through a 0.20-mm polycarbonate membrane filter
and 10 passes through a 0.10-mm polycarbonate membrane filter.
To remove the unencapsulated lanthanide complex, the liposomal
suspension was diafiltered against 300 mOsm NaCl solution using
a MicroKros module (Spectrum Laboratories, California, USA)
with a 500 kDa molecular weight cut-off.
Particle size and composition of liposomal agents
The size distribution of the resulting liposomes was determined
by dynamic light scattering (DLS) (Brookhaven 90 Plus DLS
Particle Size Analyzer) at 25uC. The lanthanide and phosphorus
concentration was quantified using inductively coupled plasma
mass spectrometer (ICP-MS, Perkin-Elmer SCIEX ELAN 6100
DRC).
Liposome stability at different temperatures
The liposomal formulation (100 mL) was re-suspended in
300 mOsm NaCl (1 mL) and was placed in a dialysis bag
(10,000 molecular weight cut-off) and dialyzed against 300 mOsm
NaCl (300 mL) at different temperatures (4uC, 25uC and 37uC).
At given time points, 1 mL of the dialysate was extracted and then
replaced with fresh buffer. The released lanthanide complex was
quantified using ICP-MS on the withdrawn aliquots.
Liposome stability at different pH values
Liposomes containing the encapsulated LnDOTA-(gly)4
2
(100 mL) were added to 1 mL of 300mOsm 2-(N-morpholi-
no)ethanesulfonate (MES) buffer for pH pH 5.5–6.5, 4-(2-hydro-
xyethyl)-1-piperazineethanesulfonate (HEPES) buffer for pH 6.5–
8.5 or TRIS buffer for pH 8.5 to 9.5. The resulting liposomal
suspensions were incubated at 37uC for 24 hours. The amount of
released lanthanide complex at different pH was determined by
dialyzing each of the samples against 300 mOsm NaCl (300 mL)
at 25uC and the dialysate was analyzed using ICP-MS.
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